Results 301 to 310 of about 175,922 (341)

Preoperative Prediction Models for 30‐Day All‐Cause Mortality After Mitral Valve Repair in Dogs: A Single‐Center Retrospective Cohort Study

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Mitral valve repair (MVR) has emerged as a novel surgical intervention for dogs with myxomatous mitral valve disease (MMVD). However, no objective risk assessment method has been established for these cases. Objectives The primary aim of this study was to develop and evaluate preoperative prediction models for 30‐day postoperative ...
Shimon Furusato   +5 more
wiley   +1 more source

Improving the quality of care for preterm infants in the golden hour. [PDF]

open access: yesBMJ Open Qual
Amuji N   +5 more
europepmc   +1 more source

Long‐Term Outcomes of Mitral Valve Repair With Artificial Chordae and Annuloplasty for Myxomatous Mitral Valve Disease in Dogs

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Myxomatous mitral valve disease (MMVD) in dogs commonly progresses to congestive heart failure, which carries a poor prognosis. Mitral valve repair (MVR) is a recognized treatment for advanced‐stage MMVD. Hypothesis/Objectives Identify the risk factors and prognosis in dogs undergoing MVR.
Kentaro Kurogochi   +6 more
wiley   +1 more source

Therapeutic Hypothermia Increases the Expression of RNA-binding Protein Motif 3 and Attenuates Cognitive Deficits Following Cardiac Arrest in Rats. [PDF]

open access: yesNeurochem Res
Yao F   +11 more
europepmc   +1 more source

Comparison of the effects of two different local anesthetics used in spinal anesthesia on peripheral and central temperature change: a randomized controlled trial. [PDF]

open access: yesBMC Anesthesiol
Ozanbarcı A   +9 more
europepmc   +1 more source

Intravascular vs. surface cooling in out-of-hospital cardiac arrest patients receiving hypothermia after hospital arrival: a post hoc analysis of the TTM2 trial. [PDF]

open access: yesIntensive Care Med
Awad A   +18 more
europepmc   +1 more source

Therapeutic modulation of protein RBM3 for ischemic stroke treatment. [PDF]

open access: yesFront Pharmacol
Ávila-Gómez P   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy